Prostate Cancer Screening

Read Our Report:

Prostate Cancer Screening Report and Recommendations (Adopted November 2015)

Prostate cancer screening is variable and may expose men to increased risk of harm, increased cost, and lower quality of life. This workgroup will identify evidence-based best practice for prostate cancer specific antigen (PSA) testing for prostate cancer screening and propose recommendations along with data-driven implementation strategies to the full Bree Collaborative.

This workgroup met from February to November 2015.

Supporting Materials:

Letter from Health Care Authority Accepting Prostate Cancer Screening Report and Recommendations
Prostate Cancer Screening Public Comments
Prostate Cancer Screening Charter


Member Title Organization
John Gore, MD, MS Urologist, clinician, surgeon, researcher University of Washington Medicine
Matt Handley, MD Associate Medical Director, Quality and Informatics Group Health Cooperative
Leah Hole-Marshall, JD Medical Administrator Department of Labor & Industries
Steve Lovell Retired Patient and Family Advisory Council
Rick Ludwig, MD (Chair) Chief Medical Officer Providence Accountable Care Organization
Bruce Montgomery, MD Clinical Director of Genitourinary Medical Oncology Seattle Cancer Care Alliance
Eric Wall, MD, MPH Market Medical Director UnitedHealthcare
Shawn West, MD Family Physician Edmonds Family Medicine
Jonathan Wright, MD, MS, FACS Assistant professor of urology/affiliate researcher University of Washington/Fred Hutchinson Cancer Research Center